Product Code: ETC9619120 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan End Stage Renal Disease Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan End Stage Renal Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan End Stage Renal Disease Market - Industry Life Cycle |
3.4 Taiwan End Stage Renal Disease Market - Porter's Five Forces |
3.5 Taiwan End Stage Renal Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan End Stage Renal Disease Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Taiwan End Stage Renal Disease Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Taiwan End Stage Renal Disease Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 Taiwan End Stage Renal Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Taiwan End Stage Renal Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of end-stage renal disease in Taiwan |
4.2.2 Technological advancements in renal replacement therapies |
4.2.3 Government initiatives to improve access to healthcare services for renal disease patients |
4.3 Market Restraints |
4.3.1 High treatment costs associated with end-stage renal disease management |
4.3.2 Limited availability of kidney donors for transplantation |
4.3.3 Regulatory challenges in the healthcare sector affecting the renal disease market in Taiwan |
5 Taiwan End Stage Renal Disease Market Trends |
6 Taiwan End Stage Renal Disease Market, By Types |
6.1 Taiwan End Stage Renal Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan End Stage Renal Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Taiwan End Stage Renal Disease Market Revenues & Volume, By Calcium Succinate, 2021- 2031F |
6.1.4 Taiwan End Stage Renal Disease Market Revenues & Volume, By Mk-3866, 2021- 2031F |
6.1.5 Taiwan End Stage Renal Disease Market Revenues & Volume, By Pacritinib, 2021- 2031F |
6.1.6 Taiwan End Stage Renal Disease Market Revenues & Volume, By Sanguinate, 2021- 2031F |
6.1.7 Taiwan End Stage Renal Disease Market Revenues & Volume, By Tesidolumab, 2021- 2031F |
6.1.8 Taiwan End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Taiwan End Stage Renal Disease Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Taiwan End Stage Renal Disease Market Revenues & Volume, By Calcimimetics, 2021- 2031F |
6.2.3 Taiwan End Stage Renal Disease Market Revenues & Volume, By Vitamin D, 2021- 2031F |
6.2.4 Taiwan End Stage Renal Disease Market Revenues & Volume, By Sterols, 2021- 2031F |
6.2.5 Taiwan End Stage Renal Disease Market Revenues & Volume, By Potassium Binders, 2021- 2031F |
6.2.6 Taiwan End Stage Renal Disease Market Revenues & Volume, By Calcium-Based, 2021- 2031F |
6.2.7 Taiwan End Stage Renal Disease Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.3 Taiwan End Stage Renal Disease Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Taiwan End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, 2021- 2031F |
6.3.3 Taiwan End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperkalaemia, 2021- 2031F |
6.3.4 Taiwan End Stage Renal Disease Market Revenues & Volume, By End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, 2021- 2031F |
6.4 Taiwan End Stage Renal Disease Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Taiwan End Stage Renal Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Taiwan End Stage Renal Disease Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Taiwan End Stage Renal Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Taiwan End Stage Renal Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Taiwan End Stage Renal Disease Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Taiwan End Stage Renal Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Taiwan End Stage Renal Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Taiwan End Stage Renal Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Taiwan End Stage Renal Disease Market Import-Export Trade Statistics |
7.1 Taiwan End Stage Renal Disease Market Export to Major Countries |
7.2 Taiwan End Stage Renal Disease Market Imports from Major Countries |
8 Taiwan End Stage Renal Disease Market Key Performance Indicators |
8.1 Average waiting time for kidney transplantation in Taiwan |
8.2 Rate of adoption of home-based dialysis treatments |
8.3 Percentage of healthcare facilities offering comprehensive renal care services |
9 Taiwan End Stage Renal Disease Market - Opportunity Assessment |
9.1 Taiwan End Stage Renal Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan End Stage Renal Disease Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Taiwan End Stage Renal Disease Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Taiwan End Stage Renal Disease Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 Taiwan End Stage Renal Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Taiwan End Stage Renal Disease Market - Competitive Landscape |
10.1 Taiwan End Stage Renal Disease Market Revenue Share, By Companies, 2024 |
10.2 Taiwan End Stage Renal Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |